{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T17:57:01Z","timestamp":1755799021147,"version":"3.44.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.exphem.2025.104821","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T11:00:56Z","timestamp":1749898856000},"page":"104821","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Gene regulatory complexes: their role and regulation across normal and malignant hematopoiesis"],"prefix":"10.1016","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8433-8994","authenticated-orcid":false,"given":"Gina","family":"Sangha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0312-161X","authenticated-orcid":false,"given":"Brian J.P.","family":"Huntly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2025.104821_bib0001","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nature25022","article-title":"From haematopoietic stem cells to complex differentiation landscapes","volume":"553","author":"Laurenti","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2025.104821_bib0002","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1093\/emboj\/cdf286","article-title":"Establishing the transcriptional programme for blood: the SCL stem cell enhancer is regulated by a multiprotein complex containing Ets and GATA factors","volume":"21","author":"Gottgens","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2025.104821_bib0003","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.cell.2006.06.052","article-title":"Multilineage transcriptional priming and determination of alternate hematopoietic cell fates","volume":"126","author":"Laslo","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2025.104821_bib0004","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.stem.2010.07.016","article-title":"Combinatorial transcriptional control in blood stem\/progenitor cells: genome-wide analysis of ten major transcriptional regulators","volume":"7","author":"Wilson","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2025.104821_bib0005","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1038\/sj.onc.1205318","article-title":"Hematopoietic cytokines, transcription factors and lineage commitment","volume":"21","author":"Zhu","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2025.104821_bib0006","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.gde.2007.12.008","article-title":"The transition from transcriptional initiation to elongation","volume":"18","author":"Wade","year":"2008","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.exphem.2025.104821_bib0007","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41586-019-1182-7","article-title":"Transcription factors and 3D genome conformation in cell-fate decisions","volume":"569","author":"Stadhouders","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2025.104821_bib0008","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41576-020-00303-x","article-title":"The relationship between genome structure and function","volume":"22","author":"Oudelaar","year":"2021","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.exphem.2025.104821_bib0009","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.molcel.2012.06.019","article-title":"DNA methylation dynamics during in vivo differentiation of blood and skin stem cells","volume":"47","author":"Bock","year":"2012","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2025.104821_bib0010","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1126\/science.1256271","article-title":"Immunogenetics. Chromatin state dynamics during blood formation","volume":"345","author":"Lara-Astiaso","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.exphem.2025.104821_bib0011","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.stem.2014.07.005","article-title":"Identification of regulatory networks in HSCs and their immediate progeny via integrated proteome, transcriptome, and DNA methylome analysis","volume":"15","author":"Cabezas-Wallscheid","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2025.104821_bib0012","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.stem.2018.04.003","article-title":"Causes and Consequences of Hematopoietic Stem Cell Heterogeneity","volume":"22","author":"Haas","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2025.104821_bib0013","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2025.104821_bib0014","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Network","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2025.104821_bib0015","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3390\/cancers13061232","article-title":"Chromatin-spliceosome mutations in acute myeloid leukemia","volume":"13","author":"Ochi","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.exphem.2025.104821_bib0016","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/s41588-023-01471-2","article-title":"In vivo screening characterizes chromatin factor functions during normal and malignant hematopoiesis","volume":"55","author":"Lara-Astiaso","year":"2023","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2025.104821_bib0017","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature09367","article-title":"Comprehensive methylome map of lineage commitment from haematopoietic progenitors","volume":"467","author":"Ji","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2025.104821_bib0018","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41556-018-0258-1","article-title":"Chromatin regulatory mechanisms and therapeutic opportunities in cancer","volume":"21","author":"Valencia","year":"2019","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.exphem.2025.104821_bib0019","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ccr.2009.11.020","article-title":"DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia","volume":"17","author":"Figueroa","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2025.104821_bib0020","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nature04431","article-title":"The polycomb group protein EZH2 directly controls DNA methylation","volume":"439","author":"Vire","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2025.104821_bib0021","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.canlet.2015.01.005","article-title":"DNMT1 and EZH2 mediated methylation silences the microRNA-200b\/a\/429 gene and promotes tumor progression","volume":"359","author":"Ning","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.exphem.2025.104821_bib0022","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1038\/s41598-017-03362-z","article-title":"EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion","volume":"7","author":"Yi","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.exphem.2025.104821_bib0023","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4161\/epi.4.6.9392","article-title":"Targeting of EZH2 to a defined genomic site is sufficient for recruitment of Dnmt3a but not de novo DNA methylation","volume":"4","author":"Rush","year":"2009","journal-title":"Epigenetics"},{"key":"10.1016\/j.exphem.2025.104821_bib0024","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026575","article-title":"Role of the polycomb repressive complex 2 (PRC2) in Transcriptional Regulation and Cancer","volume":"6","author":"Laugesen","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.exphem.2025.104821_bib0025","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ng.621","article-title":"Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders","volume":"42","author":"Ernst","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2025.104821_bib0026","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/ng.620","article-title":"Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes","volume":"42","author":"Nikoloski","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2025.104821_bib0027","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1038\/s41598-021-84708-6","article-title":"Loss-of-function mutations in the histone methyltransferase EZH2 promote chemotherapy resistance in AML","volume":"11","author":"Kempf","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.exphem.2025.104821_bib0028","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1084\/jem.20181276","article-title":"Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML","volume":"216","author":"Basheer","year":"2019","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2025.104821_bib0029","doi-asserted-by":"crossref","first-page":"6074","DOI":"10.1128\/MCB.00924-09","article-title":"Global analysis of H3K4 methylation defines MLL family member targets and points to a role for MLL1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase II","volume":"29","author":"Wang","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2025.104821_bib0030","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/nsmb.2653","article-title":"The Mll2 branch of the COMPASS family regulates bivalent promoters in mouse embryonic stem cells","volume":"20","author":"Hu","year":"2013","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.exphem.2025.104821_bib0031","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nature06145","article-title":"UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development","volume":"449","author":"Agger","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2025.104821_bib0032","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1128\/MCB.01506-06","article-title":"Knockdown of ALR (MLL2) reveals ALR target genes and leads to alterations in cell adhesion and growth","volume":"27","author":"Issaeva","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2025.104821_bib0033","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nature09692","article-title":"A unique chromatin signature uncovers early developmental enhancers in humans","volume":"470","author":"Rada-Iglesias","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2025.104821_bib0034","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.molcel.2017.06.028","article-title":"A UTX-MLL4-p300 transcriptional regulatory network coordinately shapes active enhancer landscapes for eliciting transcription","volume":"67","author":"Wang","year":"2017","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2025.104821_bib0035","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41576-020-0278-0","article-title":"COMPASS and SWI\/SNF complexes in development and disease","volume":"22","author":"Cenik","year":"2021","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.exphem.2025.104821_bib0036","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s43018-022-00366-1","article-title":"IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemia","volume":"3","author":"Aubrey","year":"2022","journal-title":"Nat Cancer"},{"key":"10.1016\/j.exphem.2025.104821_bib0037","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ccr.2009.12.040","article-title":"A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription","volume":"17","author":"Yokoyama","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2025.104821_bib0038","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1038\/onc.2016.488","article-title":"MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in 11q23 acute myeloid leukemia","volume":"36","author":"Prange","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2025.104821_bib0039","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ccr.2008.05.003","article-title":"Menin critically links MLL proteins with LEDGF on cancer-associated target genes","volume":"14","author":"Yokoyama","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2025.104821_bib0040","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1126\/science.1201662","article-title":"The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation","volume":"333","author":"Wang","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.exphem.2025.104821_bib0041","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/35901","article-title":"Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia","volume":"391","author":"Grignani","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2025.104821_bib0042","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/embo-reports\/kvf053","article-title":"Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics","volume":"3","author":"Eberharter","year":"2002","journal-title":"EMBO Rep"},{"key":"10.1016\/j.exphem.2025.104821_bib0043","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/onc.2015.92","article-title":"The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia","volume":"35","author":"Giotopoulos","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2025.104821_bib0044","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature09730","article-title":"Inactivating mutations of acetyltransferase genes in B-cell lymphoma","volume":"471","author":"Pasqualucci","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2025.104821_bib0045","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature09727","article-title":"CREBBP mutations in relapsed acute lymphoblastic leukaemia","volume":"471","author":"Mullighan","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2025.104821_bib0046","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41420-024-01940-5","article-title":"The epigenetic regulators EP300\/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia","volume":"10","author":"Wu","year":"2024","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.exphem.2025.104821_bib0047","first-page":"8732","article-title":"MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3)","volume":"94","author":"Sobulo","year":"1997"},{"key":"10.1016\/j.exphem.2025.104821_bib0048","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ccr.2004.10.015","article-title":"MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors","volume":"6","author":"Huntly","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2025.104821_bib0049","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/s40001-024-02108-8","article-title":"Histone deacetylase inhibitors for leukemia treatment: current status and future directions","volume":"29","author":"Hosseini","year":"2024","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.exphem.2025.104821_bib0050","article-title":"A histone acetyltransferase p300 inhibitor C646 induces cell cycle arrest and apoptosis selectively in AML1-ETO-positive AML cells","volume":"8","author":"Gao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2025.104821_bib0051","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1056\/NEJMra1112635","article-title":"Targeting epigenetic readers in cancer","volume":"367","author":"Dawson","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2025.104821_bib0052","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature10509","article-title":"Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia","volume":"478","author":"Dawson","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2025.104821_bib0053","first-page":"98","article-title":"Brd4 engagement from chromatin targeting to transcriptional regulation: selective contact with acetylated histone H3 and H4. F1000","volume":"1","author":"Chiang","year":"2009","journal-title":"Biol Rep"},{"key":"10.1016\/j.exphem.2025.104821_bib0054","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.molcel.2005.06.027","article-title":"The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription","volume":"19","author":"Jang","year":"2005","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2025.104821_bib0055","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022111473","article-title":"BRD4-PRC2 represses transcription of T-helper 2-specific negative regulators during T-cell differentiation","volume":"42","author":"Zhao","year":"2023","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2025.104821_bib0056","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41392-023-01647-6","article-title":"Bromodomain and extraterminal (BET) proteins: biological functions, diseases, and targeted therapy","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.exphem.2025.104821_bib0057","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature10334","article-title":"RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia","volume":"478","author":"Zuber","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2025.104821_bib0058","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/leu.2013.338","article-title":"Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia","volume":"28","author":"Dawson","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2025.104821_bib0059","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41392-020-00422-1","article-title":"Interplay between cofactors and transcription factors in hematopoiesis and hematological malignancies","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.exphem.2025.104821_bib0060","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1128\/MCB.01370-14","article-title":"TAF10 interacts with the GATA1 transcription factor and controls mouse erythropoiesis","volume":"35","author":"Papadopoulos","year":"2015","journal-title":"Mol Cell Biol"},{"issue":"50","key":"10.1016\/j.exphem.2025.104821_bib0061","doi-asserted-by":"crossref","first-page":"21541","DOI":"10.1073\/pnas.1005794107","article-title":"Specific erythroid-lineage defect in mice conditionally deficient for Mediator subunit Med1","volume":"107","author":"Stumpf","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2025.104821_bib0062","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nrm.2017.26","article-title":"Mechanisms of action and regulation of ATP-dependent chromatin-remodelling complexes","volume":"18","author":"Clapier","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.exphem.2025.104821_bib0063","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1500447","article-title":"Mammalian SWI\/SNF chromatin remodeling complexes and cancer: mechanistic insights gained from human genomics","volume":"1","author":"Kadoch","year":"2015","journal-title":"Sci Adv"},{"key":"10.1016\/j.exphem.2025.104821_bib0064","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1126\/science.8016655","article-title":"Stimulation of GAL4 derivative binding to nucleosomal DNA by the yeast SWI\/SNF complex","volume":"265","author":"Cote","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.exphem.2025.104821_bib0065","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.molcel.2023.03.013","article-title":"Structural and functional properties of mSWI\/SNF chromatin remodeling complexes revealed through single-cell perturbation screens","volume":"83","author":"Otto","year":"2023","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2025.104821_bib0066","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1101\/gad.232710.113","article-title":"Role of SWI\/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation","volume":"27","author":"Shi","year":"2013","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2025.104821_bib0067","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41586-019-1646-9","article-title":"Spliceosomal disruption of the non-canonical BAF complex in cancer","volume":"574","author":"Inoue","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2025.104821_bib0068","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1158\/2767-9764.CRC-23-0382","article-title":"The ncBAF complex regulates transcription in AML through H3K27ac sensing by BRD9","volume":"4","author":"Klein","year":"2024","journal-title":"Cancer Res Commun"},{"key":"10.1016\/j.exphem.2025.104821_bib0069","doi-asserted-by":"crossref","DOI":"10.1242\/dev.178780","article-title":"Unwinding chromatin at the right places: how BAF is targeted to specific genomic locations during development","volume":"146","author":"Ho","year":"2019","journal-title":"Development"},{"key":"10.1016\/j.exphem.2025.104821_bib0070","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1101\/gad.1642808","article-title":"The role of the chromatin remodeler Mi-2beta in hematopoietic stem cell self-renewal and multilineage differentiation","volume":"22","author":"Yoshida","year":"2008","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2025.104821_bib0071","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/bs.enz.2023.07.006","article-title":"Conserved mechanisms of NuRD function in hematopoetic gene expression","volume":"53","author":"Lenz","year":"2023","journal-title":"Enzymes"},{"key":"10.1016\/j.exphem.2025.104821_bib0072","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.molcel.2012.05.051","article-title":"Cofactor-mediated restriction of GATA-1 chromatin occupancy coordinates lineage-specific gene expression","volume":"47","author":"Chlon","year":"2012","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2025.104821_bib0073","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/s41588-019-0453-4","article-title":"Rational targeting of a NuRD subcomplex guided by comprehensive in situ mutagenesis","volume":"51","author":"Sher","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2025.104821_bib0074","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3324\/haematol.2017.183970","article-title":"The chromatin-remodeling factor CHD4 is required for maintenance of childhood acute myeloid leukemia","volume":"103","author":"Heshmati","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2025.104821_bib0075","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1182\/blood.2022016528","article-title":"HOXA9 forms a repressive complex with nuclear matrix-associated protein SAFB to maintain acute myeloid leukemia","volume":"141","author":"Agrawal-Singh","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104821_bib0076","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1126\/science.1181369","article-title":"Comprehensive mapping of long-range interactions reveals folding principles of the human genome","volume":"326","author":"Lieberman-Aiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.exphem.2025.104821_bib0077","doi-asserted-by":"crossref","first-page":"6424","DOI":"10.1016\/j.cell.2024.10.026","article-title":"The chromosome folding problem and how cells solve it","volume":"187","author":"Dekker","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2025.104821_bib0078","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/s41590-018-0184-1","article-title":"Control of inducible gene expression links cohesin to hematopoietic progenitor self-renewal and differentiation","volume":"19","author":"Cuartero","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.exphem.2025.104821_bib0079","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/ng.2759","article-title":"The landscape of somatic mutations in Down syndrome-related myeloid disorders","volume":"45","author":"Yoshida","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2025.104821_bib0080","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.stem.2015.09.017","article-title":"Leukemia-associated cohesin mutants dominantly enforce stem cell programs and impair human hematopoietic progenitor differentiation","volume":"17","author":"Mazumdar","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2025.104821_bib0081","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.stem.2019.08.003","article-title":"Cohesin members Stag1 and Stag2 display distinct roles in chromatin accessibility and topological control of HSC self-renewal and differentiation","volume":"25","author":"Viny","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2025.104821_bib0082","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1182\/blood.2019001553","article-title":"Cohesin-dependent regulation of gene expression during differentiation is lost in cohesin-mutated myeloid malignancies","volume":"134","author":"Sasca","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104821_bib0083","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neo.2021.01.003","article-title":"A cohesive look at leukemogenesis: The cohesin complex and other driving mutations in AML","volume":"23","author":"Heimbruch","year":"2021","journal-title":"Neoplasia"},{"key":"10.1016\/j.exphem.2025.104821_bib0084","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114498","article-title":"STAG2 mutations reshape the cohesin-structured spatial chromatin architecture to drive gene regulation in acute myeloid leukemia","volume":"43","author":"Fischer","year":"2024","journal-title":"Cell Rep"},{"key":"10.1016\/j.exphem.2025.104821_bib0085","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/leu.2016.240","article-title":"The cohesin subunit Rad21 is a negative regulator of hematopoietic self-renewal through epigenetic repression of Hoxa7 and Hoxa9","volume":"31","author":"Fisher","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2025.104821_bib0086","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1101\/gr.2408304","article-title":"The binding sites for the chromatin insulator protein CTCF map to DNA methylation-free domains genome-wide","volume":"14","author":"Mukhopadhyay","year":"2004","journal-title":"Genome Res"},{"key":"10.1016\/j.exphem.2025.104821_bib0087","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1042\/BJ20111417","article-title":"ADP-ribose polymers localized on Ctcf-Parp1-Dnmt1 complex prevent methylation of Ctcf target sites","volume":"441","author":"Zampieri","year":"2012","journal-title":"Biochem J"},{"key":"10.1016\/j.exphem.2025.104821_bib0088","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s41588-018-0114-z","article-title":"UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs","volume":"50","author":"Gozdecka","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2025.104821_bib0089","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41467-023-36150-7","article-title":"Chromatin complex dependencies reveal targeting opportunities in leukemia","volume":"14","author":"Najm","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2025.104821_bib0090","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1200\/JCO.24.00826","article-title":"Menin inhibition with revumenib for KMT2A-rearranged relapsed or refractory acute leukemia (AUGMENT-101)","volume":"43","author":"Issa","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2025.104821_bib0091","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/S1470-2045(24)00386-3","article-title":"Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial","volume":"25","author":"Wang","year":"2024","journal-title":"Lancet Oncol"},{"issue":"S3","key":"10.1016\/j.exphem.2025.104821_bib0092","doi-asserted-by":"crossref","DOI":"10.1097\/01.HS9.0000968924.19161.da","article-title":"P504: updated data for Ziftomenib in patients with NPM1-mutated relapsed or refractory acute myeloid leukaemia","volume":"7","author":"Fathi","year":"2023","journal-title":"HemaSphere"},{"key":"10.1016\/j.exphem.2025.104821_bib0093","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.3324\/haematol.2022.282160","article-title":"Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclax","volume":"108","author":"Rausch","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2025.104821_bib0094","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1158\/2159-8290.CD-22-0416","article-title":"A molecular switch between mammalian MLL complexes dictates response to menin-MLL inhibition","volume":"13","author":"Soto-Feliciano","year":"2023","journal-title":"Cancer Discov"},{"key":"10.1016\/j.exphem.2025.104821_bib0095","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood.2023023644","article-title":"Epigenetic regulation of noncanonical menin targets modulates menin inhibitor response in acute myeloid leukemia","volume":"144","author":"Zhou","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104821_bib0096","doi-asserted-by":"crossref","first-page":"szae089","DOI":"10.1093\/stcltm\/szae089","article-title":"Targeting chromatin modifying complexes in acute myeloid leukemia","volume":"14","author":"Schurer","year":"2025","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.exphem.2025.104821_bib0097","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1038\/s41467-019-10652-9","article-title":"Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia","volume":"10","author":"Bell","year":"2019","journal-title":"Nat Commun"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X25001122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X25001122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T15:34:03Z","timestamp":1755617643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X25001122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":97,"alternative-id":["S0301472X25001122"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2025.104821","relation":{},"ISSN":["0301-472X"],"issn-type":[{"type":"print","value":"0301-472X"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene regulatory complexes: their role and regulation across normal and malignant hematopoiesis","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2025.104821","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Society for Experimental Hematology.","name":"copyright","label":"Copyright"}],"article-number":"104821"}}